Avelumab
(Anti-human PD-L1 mAb, human IgG1-Lambda)
Catalog No.: PC-Ab1005Not For Human Use, Lab Use Only.
Avelumab is a fully human IgG1 anti-PD-L1 mAb to programmed cell death receptor ligand 1 (PD-L1), which modulates T cell immune reactivity and is used in the immunotherapy of cancer. Avelumab has major side effects and particularly immune related conditions, including acute liver injury which can be serious and even life threatening..
Avelumab is a fully human IgG1 anti-PD-L1 mAb to programmed cell death receptor ligand 1 (PD-L1), which modulates T cell immune reactivity and is used in the immunotherapy of cancer. Avelumab has major side effects and particularly immune related conditions, including acute liver injury which can be serious and even life threatening.
Physicochemical Properties
M.Wt
Formula
Human IgG1-Lambda
Appearance
Solid
CAS No.
Storage
Solide Powder
-20 °C 12 Months; 4°C 6 Months
In Solvent
-80 °C 6 Months; -20°C 6 Months
Shipping
Solubility
PBS, pH 7.0
Contains no stabilizers or preservatives
